Morning Sessions
Lymphoma
Chair: Dr. Jeffrey Bryan
Sponsored by
Time Presenter Topic
8:00 am - 9:00 am Dr. Alma Rodriguez Treatment of recurrent/refractory diffuse large B-cell
lymphomas in human adults
9:00 am - 9:20 am Dr. Jeff Bryan Canine lymphoma: Are we doing enough?
9:20 am - 9:40 am Dr. Steve Suter Transplantation to extend survival
9:40 am - 10:00 am Dr. Luca Aresu Recent advances in the understanding and treatment of canine B-cell lymphoma
10:00 am - 10:30 am Morning Break
10:30 am - 11:30 am Dr. Ari Melnick Molecular bases of B-cell lymphoma
11:30 am - 11:45 am Dr. Diana Giannuzzi Integrated analysis of RNA-seq, MBD-seq and copy number
variations in canine marginal zone and follicular lymphoma
11:45 am - 12:00 pm Dr. Sungwon Lim Individualizing chemotherapy for canine lymphoma based on ex vivo drug sensitivity test
Surgical Oncology
Chair: Dr. Carlos Souza
Sponsored by
Time Presenter Topic
8:00 am - 9:00 am Dr. Mark Scarborough Osteosarcoma in humans: A comprehensive review of surgical reconstructive techniques
9:00 am - 9:15 am Dr. Michael Deveau Methodology: Osteoplasty with custom made three-dimensional polymethylmethacrylate implants
9:15 am - 10:00 am Dr. Carlos Souza Large invasive adrenal tumors: Major challenges to improve success rate
10:00 am - 10:30 am Morning Break
10:30 am - 11:30 am Dr. Mauricio Pipkin In vivo lung perfusion and advances for treatment for lung metastasis
11:30 am - 12:00 pm Dr. Carlos Souza and
Dr. Marine TraversonControversial topics in surgical oncology
Pre-Clinical Molecular/Imaging
Chair: Dr. Doug Thamm
Sponsored by
Time Presenter Topic
8:00 am - 9:00 am Dr. Richard Gorlick Osteosarcoma: What we have learned from children’s oncology group trials and our next steps
9:00 am - 9:20 am Dr. Ryohei Yoshitake Combined treatment of BRAF/EGFR inhibitors inhibits growth of canine urothelial
carcinoma cells with BRAF mutation
9:20 am - 9:40 am Dr. Robin Holland IB-DNQ as a dual-acting immunochemotherapeutic for controlling local
and metastatic transitional cell carcinoma
9:40 am - 10:00 am Dr. Julia Matera Intra-tumoral injection of Tigilanol Tiglate in canine mast cell tumors:
Time-assessed thermographic images, computed tomography and clinical response
10:00 am - 10:30 am Morning Break
10:30 am - 11:30 am Dr. Amy LeBlanc Comprehensive molecular imaging: Challenges & opportunities
11:30 am - 12:00 pm Panel Discussion
Afternoon Concurrent Sessions
Immunotherapy/Translational Medicine
Chair: Dr. Antonella Borgatti
Sponsored by
Time Presenter Topic
1:30 pm - 2:30 pm Dr. Nicola Mason Immunotherapy in companion animals: The successes, failures and barriers to overcome
2:30 pm - 2:45 pm Dr. Rowan Milner Survival data from the osteosarcoma University of Florida nanoscaled
MPL-Liposome ganglioside (GD3) vaccine trial
2:45 pm - 3:00 pm Dr. Jeannette Kelly Concurrent use of chemotherapy and Immunocidin® for treatment of
canine lymphoma and osteosarcoma
3:00 pm - 3:30 pm Afternoon Break
3:30 pm - 4:30 pm Dr. Bruce Walcheck Expression of recombinant Fc receptors by engineered NK cells for
universal tumor antigen targeting
4:30 pm - 4:45 pm Dr. Sho Yoshimoto Comparison of different intracellular signaling domains in canine chimeric antigen receptor T cells
4:45 pm - 5:00 pm Dr. Shay Bracha Tumor reactive immune margin of bone marrow from appendicular osteosarcoma
patients correspond with disease-free interval
Radiation/Interventional Radiation
Chair: Dr. Michael Nolan
Sponsored by
Time Presenter Topic
1:30 pm - 2:30 pm Dr. Marine Traverson Novel interventional limb-sparing approach to bone tumors in veterinary medicine
2:30 pm - 2:45 pm Dr. Franck Floch Proof of concept of arterial chemoembolization for treatment of prostatic carcinoma in dogs
2:45 pm - 3:00 pm Dr. Olivier Keravel Treatment of feline fibrosarcoma with wide surgical excision and intraoperative
orthovoltage irradiation: Preliminary results
3:00 pm - 3:30 pm Afternoon Break
3:30 pm - 4:30 pm Dr. Michael Kent Radioimmunotherapy: What is the role of radiation therapy?
4:30 pm - 5:00 pm Panel Discussion
Molecular Diagnostics
Chair: Dr. Steven Suter
Sponsored by
Time Presenter Topic
1:30 pm - 2:30 pm Dr. Matthew Breen Opportunities for new molecular diagnostics in veterinary oncology
2:30 pm - 3:00 pm Dr. Chand Khanna A clinician’s perspective on molecular diagnostics in oncology
3:00 pm - 3:30 pm Afternoon Break
3:30 pm - 4:30 pm Dr. Steven Suter Two useful molecular diagnostic tests for veterinary oncologists
4:30 pm - 5:00 pm Dr. Chand Khanna Molecular approaches to canine hemangiosarcoma